WO2008014665A1 - Intervertebral disk transplant and implantation method - Google Patents
Intervertebral disk transplant and implantation method Download PDFInfo
- Publication number
- WO2008014665A1 WO2008014665A1 PCT/CN2007/002024 CN2007002024W WO2008014665A1 WO 2008014665 A1 WO2008014665 A1 WO 2008014665A1 CN 2007002024 W CN2007002024 W CN 2007002024W WO 2008014665 A1 WO2008014665 A1 WO 2008014665A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disk
- intervertebral
- cells
- patient
- normal saline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3612—Cartilage, synovial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
- A61L27/3658—Intervertebral discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
- A61L27/3852—Cartilage, e.g. meniscus
- A61L27/3856—Intervertebral discs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/44—Joints for the spine, e.g. vertebrae, spinal discs
- A61F2/442—Intervertebral or spinal discs, e.g. resilient
- A61F2002/445—Intervertebral disc tissue harvest sites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
A natural spinal disk including adjacent vertebral structures is removed from a deceased donor, rinsed in normal saline, preserved in a cryopreservative solution, and then frozen by gradually decreasing the temperature using liquid nitrogen or similar method. The implant may be thawed in normal saline solution and then implanted in a patient in need of a vertebral disk replacement.
Description
INTERVERTEBRAL DISK TRANSPLANT AND IMPLANTATION METHOD
CROSS REFERENCE TO RELATED APPLICATION
This application claims priority based on U.S. Provisional Patent Application No. 60/820,378, filed June 26, 2006, the entire contents of which are incorporated herein by reference.
FIELD OF THE INVENTION
This invention relates to an intervertebral disk transplant, and to methods of preparing, preserving, and implanting such a disk transplant.
BACKGROUND OF THE INVENTION
Intervertebral disks provide mobility and a shock cushion between the vertebrae. Anatomically, a disk includes the nucleus pulposus in the center, which is composed of cells and an insoluble extracellular matrix which is produced by the nucleus itself. The extracellular matrix is composed of collagen, proteoglycans, and water. The nucleus pulposus is surrounded by the annulus fibrosis, which is also composed of cells (fibrocyte and chondrocyte), collagen fibers, and an extracellular matrix. The endplates are attached to the bony tissue, the vertebrae.
To date, there are a few treatments for degenerative disk disease. Spinal fusion has been widely used to obtain mechanical support and stability in various clinical situations,
such as degenerative disk disease or infective and malignant conditions that induce spinal instability, Although results are satisfactory in most cases, long term complications, such as adjacent-segment degeneration, have been reported and remain an issue. The mechanism of this degeneration is still unclear. Cadaver studies demonstrated increasing intradisk pressures in the adjacent unfused intervertebral disks after a simulated spinal fusion. Retrospective clinical analysis suggested that the risk of adjacent-segment failure is higher for patients in whom lumbar fusion with rigid instrumentation is performed. A few studies indicate that the altered mechanical environment after short rigid spinal fusion lead to the accelerated adjacent segment degeneration.
To avoid altering the biomechanical function of the intervertebral joint, efforts have been made to develop an artificial disk, as reported a few issued patents (U.S. Patent Nos. 6,958,078, 6,989,032, and 6,692,495 (all incorporated by reference herein)). Some of the difficulties with such developments include implant fixation, biocompatibility, and the identification of suitable materials and designs, which duplicate both form and function. Clinically, devices that replace a total disk exhibit certain weaknesses. Total disk replacements rely on attachments of the artificial disk to the vertebral endplates. Various methods of attachment have been described including the use of screws, spikes, and porous ingrowth material. The total disk/vertebral interface can loosen due to non-natural biomaterials. The problems with prosthesis loosening and revision surgery of the same are reported to be similar to that encountered with total knee and hip replacement surgery. As such, the long term outcomes of total replacement by artificial disks are still under review.
The desired treatment for degenerative disk disease therefore lies in treatment which preserves natural disk function. If disk function could be restored with biologic natural disk replacement, the weaknesses of current artificial disk replacement would be minimized, if not eliminated.
SUMMARY OF THE INVENTION
This invention provides a method for treating degenerated, diseased or traumatized human intervertebral disks of the spine. According to the method, a natural allograft disk unit is harvested from a fresh human donor. This donor disk unit preferably includes an intervertebral disk including all of its structures, including the nucleus pulposus, the annulus fibrosis, the extracellular matrix, the endplates, and a portion of the vertebrae bony tissue on either side of the disk.
The donor disk unit can be engineered and processed to alter, stimulate, remove, or insert living cells therein using methods such as temperature changes, saline or other solution washes, and shape osteotomy. The extracellular matrix and original cells may be preserved. Other related cells, for example, nucleus pulposus, annulus fibrosis cells, and stem cells are cultured and transplanted into the natural allograft disk,
The transplantation is surgically performed, and the degenerated or diseased disk is removed from the patient, including the vertebral endplates and a portion of the bony vertebra from less than 1 mm to a whole segment on either side of the disk, thereby creating a void to be filled, The natural allograft disk is positioned within the surgically
created void. The invention further includes the procedures to insert, inject or surgically input one or more tissues, cells, scaffolds or substances to the natural allograft disk.
BRIEF DESCRIPTION OF THE DRAWINGS
Further features and advantages of the invention may be understood by reference to the following detailed description of the preferred embodiments, reviewed in conjunction with the following drawings in which:
FIG. 1A is an x-ray of the spine of a patient before implantation of the allograft spinal disk of the present invention; and
FIG. 1 B is an x-ray of the spine of the same patient after implantation of the allograft spinal disk of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
This invention relates to a method of treating a degenerated, diseased or traumatized human intervertebral disk of the spine. According to the method, a natural allograft disk is harvested from a fresh human donor. This natural allograft preferably includes an intervertebral disk having all parts of its structure, namely the nucleus pulposus, the annulus fibrosis, the extracellular matrix, the endplates, and a portion of the vertebrae bony tissue from less than 1 mm to the whole bony vertebrae on either side of the disk. The natural allograft disk can further include growth factors, proteins, cytokines, culture media, differentiation factors, hydrogels, artificial scaffolds, antibiotics and/or useful combinations thereof. This natural allograft disk is used to restore function, and to reduce or eliminate pain in patients with degenerative or other disk disease.
Guidelines for tissue procurement including surgical technique of removal, number of hours between death of the donor and tissue procurement, and testing of the donor for infectious disease, are well described in the literature.
Preparation of the Natural Allograft Disk: The spinal column from C1 to S1 of a human donor removed up to a few hours after death is used to produce the natural allograft disk. The donor spine has to test negative for infectious diseases, as described in literature. After removal of the surrounding muscles, posterior elements, and other soft tissues, osteotomy is made at the endplates from less than 1 mm above and below the disk to including the whole vertebra. The disk grafts obtained are washed with saline solution, for example, and immersed in RPMI-1640 cryopreservative solution (10% dimethyl sulfoxide [DMSO] or similar solution) for ten minutes to 2 hours or for any longer time if needed, at 0° C or 4° C up to 20O0C. The temperature is then reduced stepwise to 0° and then to -15° C for 1 hour, then to -40° C for 1 hour, or any useful combination thereof, and then -80° C for 1 hour, after which the disk grafts are preserved in liquid nitrogen (-196° C or lower) until surgery. The preservation period can be from one day to two years.
The natural allograft disk can be an autograft, allograft or xenograft disk comprising partially or fully decellularized anulus fibrosus, endplates and nucleus pulposus tissue of a donor vertebra. The annulus fibrosus, endplates and nucleus pulposus tissue can be cross-linked naturally or artificially. The cross-linked annulus fibrosus, endplates, and nucleus pulposus can be combined with natural or artificial scaffolds injected or surgically inserted. Preferably, the donor spinal column section is removed at the
endplates approximately 0 to 60 mm above and below the donor vertebrae or disks. The disk has a predetermined 3-dimensional shape, with a width of about 5-70 mm, a depth of about 5-50 mm, and a height of about 0.5-30 mm.
After removal from the donor, the disk is washed with saline and immersed in a preservative solution such as RPMI-1640 cryopreservative solution (10% dimethyl sulfoxide [DMSO] and/or serum) for 1 minute to one month.
The temperature can also be reduced stepwise or continuously in liquid nitrogen or other liquefied gas such as helium in a laboratory freezer, or with dried ice to 00C, then to -4O0C1 then to -8O0C and then finally to -2000C where the disk is preserved in liquid nitrogen or other suitably cold fluid, or in a cryogenic freezer.
Following disk preservation, the natural allograft disk is used to replace a degenerated, diseased or traumatized human intervertebral space. Surgical techniques to remove the disk and a portion of the vertebrae are well known to spine surgeons. The natural allograft disk is either not affixed or affixed using a fixation method including suturing, tissue glue, or an adhesive bonding material to surrounding tissues of the said disk area to be treated. A resorbable or nonresorbable bone implant material can be used where deemed beneficial to help affix the disk to the adjacent bone. The natural allograft disk is then placed into the surgically created void. The surgical procedure can be as follows, for example;
With the patient under general anesthesia, the diseased intervertebral disk is exposed. After removal of the diseased disk and the adjacent bony endplates, the preserved natural allograft disk of the most compatible size is selected and quickly thawed by immersion in physiologic saline at 370C. The disk allograft is then positioned into the slot of the excised disk without internal fixation. On recovering from anesthesia, the patient is allowed free mobilization in a few hours to a few days with or without external support.
Growth factors, such as bone morphogenic proteins, living cells and stem cells are added to the natural allograft before and/or during the surgery, and a few hours, or a few weeks, or months following the surgery. The delayed insertion of the living cells may allow revascularization of the donor bony endplates prior to cell insertion. This endplate revascularization is important for diffusion of nutrition to and from the transplanted natural allograft disk cells. Alternatively, the living cells, growth factors, or other related substances can be added to the natural allograft before, during and after surgical transplantation.
Radiological Assessment is carried out before, during and after surgical transplantation as in Fig. 1. Anteroposterior and lateral radiographs of the transplanted spine unit of the patient can be taken before surgery and immediately after the surgery, and at any period of time post surgery. The anterior, middle, and posterior disk heights are measured on the lateral radiographs using a computerized digitizer. Segmental motion can be monitored by dynamic flexion-extension radiographs. The status of hydration or degeneration of the transplanted disk can be monitored with MRI.
References Cited
The following references are incorporated by reference herein:
U.S. Patent No.: 5,893,889
U.S. Patent No.: 5,899,941
U.S. Patent No.: 5,928,284
U.S. Patent No.: 6,080,579
U.S, Patent No.: 6,231 ,615
U.S. Patent No.: 6,228,118
U.S. Patent No.: 6,245,107
U.S. Patent No.: 6,332,779
U.S. Patent No.: 6,340,369
U.S. Patent No.: 6,352,558
U.S. Patent No.: 6,454,804
U.S. Patent No.: 6,648,919
U.S. Patent No.: 5,682,562
U.S. Patent No.: 6,692,495
U.S. Patent No.: 6,706,068
U.S. Patent No.: 6,716,245
U.S. Patent No.: 6,958,078
U.S. Patent No.: 6,989,032
The Invention has been described with reference to the preferred embodiments. Various modifications can be made without departing from the spirit and scope of the invention. It is therefore intended that the invention be defined by the following claims.
Claims
1. A method for preparing and preserving an intervertebral disk for transplantation from one human to another, comprising: obtaining surgical access to an intervertebral disk in a recently deceased or soon to be deceased patient; removing the intervertebral disk including at least a portion of bony vertebrae on each side thereof; rinsing the intervertebral disk with normal saline; immersing the intervertebral in a cryopreserative solution; and freezing the disk by gradually reducing the temperature thereof stepwise to about O0C, then to about -150C, then to about -400C, then to about -8O0C; and maintaining the frozen disk at a temperature below about -1500C.
2. A method according to claim 1 , wherein the disk is preserved in liquid nitrogen,
3. A method according to claim 2, wherein the disk is thawed after preservation by immersing the disk in saline at room or body temperature.
4. A method of replacing a damaged intervertebral disk in a patient comprising: obtaining surgical access to the damaged intervertebral disk and removing the disk along with a portion of bony vertebrae on both sides of the disk; inserting an intervertral disk having a portion of bony vertebrae on both sides of thereof harvested from a deceased donor patient, the intervertral disk being rinsed with normal saline, preserved in a cryopreservative solution and then frozen stepwise to about 00C, then to about - 150C, then to about - 4O0C, then to about -8O0C, then to about -15O0C and then thawed to room or body temperature.
5. A method according to claim 4, wherein growth factors, living disk cells, or stem cells are added to the disk before, during, or after surgery.
6. A method according to claim 2, wherein the disk is frozen in liquid nitrogen,
7. A method according to claim 4, wherein the implant is thawed by immersion in normal saline solution.
8. A method according to claim 4, wherein growth factors, cytokines, differentiation factors, hydrogels, artificial scaffolds, antibiotics, living cells including stem cells, or living disk cells are added to the disk or the region adjacent the disk before, during or after surgery.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007800282114A CN101495067B (en) | 2006-07-26 | 2007-06-28 | Intervertebral disk transplant and implantation method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82037806P | 2006-07-26 | 2006-07-26 | |
US60/820,378 | 2006-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008014665A1 true WO2008014665A1 (en) | 2008-02-07 |
Family
ID=38996862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2007/002024 WO2008014665A1 (en) | 2006-07-26 | 2007-06-28 | Intervertebral disk transplant and implantation method |
Country Status (3)
Country | Link |
---|---|
US (1) | US8048618B2 (en) |
CN (1) | CN101495067B (en) |
WO (1) | WO2008014665A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10786235B2 (en) | 2012-10-31 | 2020-09-29 | Anchor Innovation Medical, Inc. | Method and apparatus for closing a fissure in the annulus of an intervertebral disc, and/or for effecting other anatomical repairs and/or fixations |
US9433404B2 (en) | 2012-10-31 | 2016-09-06 | Suture Concepts Inc. | Method and apparatus for closing fissures in the annulus fibrosus |
CA2920546A1 (en) | 2013-08-16 | 2015-02-19 | Suture Concepts Inc. | Method and apparatus for closing a fissure in the annulus of an intervertebral disc, and/or for effecting other anatomical repairs and/or fixations |
US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
CN111876379A (en) * | 2020-07-15 | 2020-11-03 | 师浩钧 | Method for efficiently promoting proliferation of fiber ring source stem cells |
WO2022020210A1 (en) | 2020-07-18 | 2022-01-27 | Ossium Health, Inc. | Permeation of whole vertebral bodies with a cryoprotectant using vacuum assisted diffusion |
AU2021360590A1 (en) | 2020-10-14 | 2023-06-15 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
EP4262831A1 (en) | 2020-12-18 | 2023-10-25 | Ossium Health, Inc. | Methods of cell therapies |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528469A (en) * | 2003-10-09 | 2004-09-15 | 中国人民解放军南京军区南京总医院 | Method for preparing and preserving homogeneous bone tissue with biological activity |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5108438A (en) * | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
US6352558B1 (en) * | 1996-02-22 | 2002-03-05 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Method for promoting regeneration of surface cartilage in a damage joint |
US5893889A (en) * | 1997-06-20 | 1999-04-13 | Harrington; Michael | Artificial disc |
CN1271262A (en) * | 1997-08-04 | 2000-10-25 | 弋登玛雅,罗伯特&托马斯第一有限责任公司 | Multiple axle intervertebral prosthesis |
US6309420B1 (en) * | 1997-10-14 | 2001-10-30 | Parallax Medical, Inc. | Enhanced visibility materials for implantation in hard tissue |
US6080579A (en) * | 1997-11-26 | 2000-06-27 | Charlotte-Mecklenburg Hospital Authority | Method for producing human intervertebral disc cells |
US5899941A (en) * | 1997-12-09 | 1999-05-04 | Chubu Bearing Kabushiki Kaisha | Artificial intervertebral disk |
US5928284A (en) * | 1998-07-09 | 1999-07-27 | Mehdizadeh; Hamid M. | Disc replacement prosthesis |
US6340369B1 (en) * | 1999-08-13 | 2002-01-22 | Bret A. Ferree | Treating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix |
US6245107B1 (en) * | 1999-05-28 | 2001-06-12 | Bret A. Ferree | Methods and apparatus for treating disc herniation |
US6454804B1 (en) * | 1999-10-08 | 2002-09-24 | Bret A. Ferree | Engineered tissue annulus fibrosis augmentation methods and apparatus |
FR2799638B1 (en) * | 1999-10-14 | 2002-08-16 | Fred Zacouto | FIXATOR AND VERTEBRAL JOINT |
US6648919B2 (en) * | 1999-10-14 | 2003-11-18 | Bret A. Ferree | Transplantation of engineered meniscus tissue to the intervertebral disc |
FR2805985B1 (en) * | 2000-03-10 | 2003-02-07 | Eurosurgical | INTERVERTEBRAL DISK PROSTHESIS |
US6332779B1 (en) * | 2000-07-03 | 2001-12-25 | Osteotech, Inc. | Method of hard tissue repair |
FR2811543B1 (en) * | 2000-07-12 | 2003-07-04 | Spine Next Sa | INTERSOMATIC IMPLANT |
US6989032B2 (en) * | 2001-07-16 | 2006-01-24 | Spinecore, Inc. | Artificial intervertebral disc |
US6706068B2 (en) * | 2002-04-23 | 2004-03-16 | Bret A. Ferree | Artificial disc replacements with natural kinematics |
US6958078B2 (en) * | 2002-08-19 | 2005-10-25 | The University Of Toledo | Bioartificial intervertebral disc |
-
2007
- 2007-06-27 US US11/768,983 patent/US8048618B2/en active Active
- 2007-06-28 WO PCT/CN2007/002024 patent/WO2008014665A1/en active Application Filing
- 2007-06-28 CN CN2007800282114A patent/CN101495067B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1528469A (en) * | 2003-10-09 | 2004-09-15 | 中国人民解放军南京军区南京总医院 | Method for preparing and preserving homogeneous bone tissue with biological activity |
Non-Patent Citations (1)
Title |
---|
YUAN D. ET AL.: "(NANJING GEN HOSPITAL NANJING MILITARY RE)", CHINESE JOURNAL OF ORTHOPAEDICS, vol. 19, no. 1, January 1999 (1999-01-01), pages 55 * |
Also Published As
Publication number | Publication date |
---|---|
US20080027551A1 (en) | 2008-01-31 |
CN101495067A (en) | 2009-07-29 |
US8048618B2 (en) | 2011-11-01 |
CN101495067B (en) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8048618B2 (en) | Method for preparing and preserving a natural allograft intervertebral disk for humans | |
US6344058B1 (en) | Treating degenerative disc disease through transplantation of allograft disc and vertebral endplates | |
Schimmel et al. | Acetabular reconstruction with impacted morselized cancellous allografts in cemented hip arthroplasty: a histological and biomechanical study on the goat | |
Heuer et al. | Biomechanical evaluation of conventional anulus fibrosus closure methods required for nucleus replacement | |
Carl et al. | New developments in nucleus pulposus replacement technology | |
US6685695B2 (en) | Method and apparatus for providing nutrition to intervertebral disc tissue | |
Kaufman et al. | The principles of bony spinal fusion | |
US6793677B2 (en) | Method of providing cells and other biologic materials for transplantation | |
US20170304058A1 (en) | Implant for Repairing a Cartilage Defect | |
US20040049270A1 (en) | Bone graft device | |
US20070009610A1 (en) | Engineered osteochondral construct for treatment of articular cartilage defects | |
JP2010510026A (en) | Method and apparatus for minimally invasive modular interbody fusion device | |
AU2008288225A1 (en) | Articular cartilage, device and method for repairing cartilage defects | |
KR20010043022A (en) | Apparatus and method for spinal fusion using implanted device | |
US9622880B2 (en) | Mesenchymal cell-based soft fusion as a biological intervertebral disc replacement | |
Salame et al. | The use of carbon fiber cages in anterior cervical interbody fusion: report of 100 cases | |
US20200337847A1 (en) | Graft for repairing articular cartilage defects and method for the same | |
WO2003066120A1 (en) | Treating degenerative disc disease through transplantation of allograft disc | |
Zatsepin et al. | Replacement of the distal femur and proximal tibia with frozen allografts | |
RU2692228C1 (en) | Method for surgical treatment of chondro-osseous defects of femoral condyles | |
Rees et al. | Bone transplantation | |
CN1528469A (en) | Method for preparing and preserving homogeneous bone tissue with biological activity | |
Kebdani et al. | Biomechanical comparison between two models of the lumbar Intersomatic fusion cage analyzed by the finite element method | |
Palmer et al. | (3381)-Correlation of radiographic parameters to clinical outcomes of transforaminal lumbar interbody fusion vs. Lateral lumbar interbody fusion for degenerative lumbar spondylolisthesisC. | |
Jancewicz et al. | Knee Osteochondral Defect Reconstruction With Autologous Bone Grafting and Mesenchymal Cell Transplantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780028211.4 Country of ref document: CN |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07763967 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07763967 Country of ref document: EP Kind code of ref document: A1 |